约旦多病症患者的药物坚持:在门诊诊所进行的横截面混合方法研究
Anas Abed1, Mohammad Abu Assab2, Wael Abu Dayyih3
1Department of Biopharmaceutics and Clinical Pharmacy, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan.
Frontiers in pharmacology
|August 18, 2025
概括
在多种慢性疾病的约旦成年人中,药物坚持率为54.3%. 关键障碍包括成本和遗忘,而年龄较大和收入较高改善了遵守,为目标干预提供了信息.
科学领域:
- 公共卫生 公共卫生
- 制药科学 制药科学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 在约旦,多种疾病的患病率正在上升,约旦是一个中等收入国家,面临着越来越多的非传染性疾病 (NCD) 负担.
- 有限的数据存在约旦多种慢性疾病的个人的药物坚持.
- 本研究探讨了理解遵守的必要性,以支持可持续发展目标3.
研究的目的:
- 确定约旦多病症患者药物坚持的流行率.
- 为了确定与这种人群中药物坚持相关的预测因素和障碍.
- 为制定有针对性的干预措施提供信息,以改善遵守.
主要方法:
- 这是一项横截面,混合方法的研究,涉及约旦安曼的405名成年人,他们患有两个或两个以上的慢性疾病.
- 使用通用药物坚持度表 (GMAS) 评估了药物坚持度.
- 收集了关于障碍和促进者的定性数据,并根据主题进行了分析.
主要成果:
- 在54.3%的参与者中观察到高药物坚持 (GMAS ≥27).
- 坚持的积极预测因素包括年龄较大,收入较高,药物较少,更高的健康素养和社会支持.
- 确定的主要障碍是成本,多药,遗忘,农村居住和低感知药物必要性.
结论:
- 这项研究为约旦多病症患者的药物坚持提供了第一个见解.
- 确定了可行的障碍和促进因素,为资源有限的环境提供了一个可扩展的模型.
- 建议包括补贴,移动药房和文化定制的策略,以减少不遵守并推进NCD控制.
相关概念视频
01:28Drug Therapy
97
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
97
01:28Chronic Kidney Disease III: Interprofessional Care
78
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
78
01:15Methods of Documentation VI: Case Management Model
628
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
628
01:21Rheumatic Heart Disease III: Medical Management
32
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
32
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
01:15Drug Dosage Regimen: Overview
3.8K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.8K